Vol. 90 No. 7-S (2019): The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders: Guest Editor: Giorgio Ciprandi

View Vol. 90 No. 7-S (2019): The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders: Guest Editor: Giorgio Ciprandi
Published: 09-07-2019

  • The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders

    DOI: https://doi.org/10.23750/abm.v90i7-S.8648
    Giorgio Ciprandi, Salvo Emanuele Aragona, Lorenzo Drago, Ignazio La Mantia
    5-7

  • Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders

    DOI: https://doi.org/10.23750/abm.v90i7-S.8649
    Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
    8-12

  • Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

    DOI: https://doi.org/10.23750/abm.v90i7-S.8650
    Luigi Bonavina, Andrea Ariani, Leonardo Ficano, Domenico Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Lorenzo Drago, Giorgio Ciprandi, Italian Study Group on digestive disorders
    13-17

  • Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01)

    DOI: https://doi.org/10.23750/abm.v90i7-S.8651
    Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
    18-23

  • Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice

    DOI: https://doi.org/10.23750/abm.v90i7-S.8654
    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    24-29

  • Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

    DOI: https://doi.org/10.23750/abm.v90i7-S.8655
    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    30-35

  • Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

    DOI: https://doi.org/10.23750/abm.v90i7-S.8656
    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    36-40

  • VAS for assessing the perception of antihistamines use in allergic rhinitis

    DOI: https://doi.org/10.23750/abm.v90i7-S.8657
    Giorgio Ciprandi, Ignazio La Mantia
    41-44

  • Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers

    DOI: https://doi.org/10.23750/abm.v90i7-S.8658
    Calogero Grillo, Ignazio La Mantia, Caterina M Grillo, Giorgio Ciprandi, Martina Ragusa, Claudio Andaloro
    45-51

  • Oral health in children with sleep-disordered breathing: a cross-sectional study

    DOI: https://doi.org/10.23750/abm.v90i7-S.8661
    Calogero Grillo, Ignazio La Mantia, Graziano Zappala, Salvatore Cocuzza, Giorgio Ciprandi, Claudio Andaloro
    52-59